Evaluation of kidney function among people living with HIV initiating antiretroviral therapy in Zambia.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
07
2021
accepted:
09
01
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
As the response to the HIV epidemic in sub-Saharan Africa continues to mature, a growing number of people living with HIV (PLHIV) are aging and risk for non-communicable diseases increases. Routine laboratory tests of serum creatinine have been conducted to assess HIV treatment (ART) suitability. Here we utilize those measures to assess kidney function impairment among those initiating ART. Identification of non-communicable disease (NCD) risks among those in HIV care creates opportunity to improve public health through care referral and/or NCD/HIV care integration. We estimated glomerular filtration rates (eGFR) using routinely collected serum creatinine measures among a cohort of PLHIV with an HIV care visit at one of 113 Centre for Infectious Disease Research Zambia (CIDRZ) supported sites between January 1, 2011 and December 31, 2017, across seven of the ten provinces in Zambia. We used mixed-effect Poisson regression to assess predictors of eGFR <60ml/min/1.73m2 allowing random effects at the individual and facility level. Additionally, we assessed agreement between four eGFR formulae with unadjusted CKD-EPI as a standard using Scott/Fleiss method across five categories of kidney function. A total of 72,933 observations among 68,534 individuals met the inclusion criteria for analysis. Of the 68,534, the majority were female 41,042 (59.8%), the median age was 34 (interquartile range [IQR]: 28-40), and median CD4 cell count was 292 (IQR: 162-435). The proportion of individuals with an eGFR <60ml/min/1.73m2 was 6.9% (95% CI: 6.7-7.1%) according to the unadjusted CKD-EPI equation. There was variation in agreement across eGFR formulas considered compared to unadjusted CKD-EPI (χ2 p-value <0.001). Estimated GFR less than 60ml/min/1.73m2, per the unadjusted CKD-EPI equation, was significantly associated with age, sex, body mass index, and blood pressure. Using routine serum creatinine measures, we identified a significant proportion of individuals with eGFR indicating moderate or great kidney function impairment among PLHIV initiating ART in Zambia. It is possible that differentiated service delivery models could be developed to address this subset of those in HIV care with increased risk of chronic kidney disease.
Identifiants
pubmed: 36962175
doi: 10.1371/journal.pgph.0000124
pii: PGPH-D-21-00415
pmc: PMC10021838
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000124Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright: © 2022 Pry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
None of the authors have competing interests.
Références
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Antivir Ther. 2007;12(8):1165-73
pubmed: 18240857
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):1002-1009
pubmed: 33625064
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
AIDS Behav. 2019 Mar;23(3):557-563
pubmed: 30796638
Top Antivir Med. 2019 Apr;27(1):50-68
pubmed: 31137003
Contemp Clin Trials. 2012 Nov;33(6):1280-6
pubmed: 22813645
AIDS. 2010 Jul 17;24(11):1667-78
pubmed: 20523203
Lancet. 2012 Nov 10;380(9854):1649-61
pubmed: 23013600
Lancet Glob Health. 2014 Mar;2(3):e174-81
pubmed: 25102850
AIDS. 2008 Sep 12;22(14):1821-7
pubmed: 18753939
Clin Infect Dis. 2013 Feb;56(4):567-75
pubmed: 23143096
Am J Kidney Dis. 2012 Oct;60(4):539-47
pubmed: 22521282
PLoS One. 2017 Sep 20;12(9):e0184766
pubmed: 28931037
PLoS Med. 2020 Jul 1;17(7):e1003116
pubmed: 32609756
AIDS. 2011 Jul 17;25(11):1421-5
pubmed: 21572304
Clin J Am Soc Nephrol. 2011 Aug;6(8):1963-72
pubmed: 21737852
Hypertension. 2020 Jan;75(1):229-236
pubmed: 31786971
Clin Infect Dis. 2020 Mar 17;70(7):1267-1274
pubmed: 31100116
Curr HIV/AIDS Rep. 2019 Aug;16(4):324-334
pubmed: 31230342
J Med Trop. 2012;14(1):1-6
pubmed: 25243111
HIV Med. 2021 Feb;22(2):83-91
pubmed: 32985122
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Lancet. 2013 Jul 13;382(9887):170-9
pubmed: 23727171
Afr J Emerg Med. 2016 Mar;6(1):38-43
pubmed: 30456062
Haematologica. 2019 Dec;104(12):2501-2511
pubmed: 30890598
J Hum Hypertens. 2016 Apr;30(4):221-2
pubmed: 26377356
Ann Intern Med. 2004 Dec 21;141(12):929-37
pubmed: 15611490
Lancet. 2013 Jul 13;382(9887):158-69
pubmed: 23727165
BMC Med Inform Decis Mak. 2009 Sep 11;9:42
pubmed: 19747371
Science. 2013 Feb 22;339(6122):961-5
pubmed: 23430655
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
PLoS One. 2016 Oct 14;11(10):e0164753
pubmed: 27741309
Nephron. 1976;16(1):31-41
pubmed: 1244564
Clin Infect Dis. 2005 Apr 15;40(8):1194-8
pubmed: 15791522
Nat Rev Nephrol. 2009 Oct;5(10):591-8
pubmed: 19776781
AIDS. 2010 Jan 28;24(3):387-94
pubmed: 20019575
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650
pubmed: 28770594
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
Glob Public Health. 2017 Apr;12(4):396-415
pubmed: 26948138
Am J Kidney Dis. 2011 Dec;58(6):886-93
pubmed: 21944667
J Clin Hypertens (Greenwich). 2019 Nov;21(11):1693-1694
pubmed: 31553122